TORPEdO - Phase III Trial of IMPT Vs IMRT for Multi-toxicity Reduction in Oropharyngeal Cancer.
07/10/2019
/
Publications
/
IMPT
Chemotherapy
IMRT
This is the UK's first proton clinical trial. Published in the Clinical Oncology, this editorial provided the rational and the plan of the trial. It is a...
Model-Based Approach to Predict ST Toxicity Benefits With PT for Oropharyngeal Cancer.
01/01/2019
/
Publications
/
Model-based approach
A study by UPenn and Groningen. For patients with advanced-stage oropharynx cancer treated with curative intent (PBT, n = 30; IMRT, n = 175), NTCP models were...
Strategy Identifying Which Oropharyngeal H&N Cancer Patients may Benefit the Most from Proton Radiation Therapy.
11/11/2018
/
Publications
/
Published in the Red Journal, this study detailed the model base approach for identifying patients for proton treatment. NTCP models for dysphagia, esophagitis...
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
10/10/2021
/
Publications
/
Radiation-induced optic neuropathy (RION) is a rare side effect following radiation therapy. A multi-institutional cohort including 289 skull-base cancer...
Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
26/11/2021
/
Publications
/
IMPT
IMRT
This is a cost-effectiveness study from China. A Markov model is used with the assumption that IMPT offered NTCP reduction in long-term dysphagia, xerostomia...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.